Takeaways
#- Glick described a sideways session where repeated small trades could erode earlier gains.
- Sprouts remained a hold while its invalidation area survived, followed by a partial-sale discussion when price advanced.
- His QQQ short was completed early; a possible next-day short depended on a new sequence developing.
- He contrasted selling Meta too quickly with waiting through a stalled Novavax position that remained open.
Kenny Glick had a name for the market on October 30, 2025: “squadouch.” He used it to describe movement that went nowhere, with advances meeting sellers and declines meeting buyers.
He had already made money on a QQQ short and wanted to protect the day's progress. The obvious danger was giving it back through a series of small trades in the chop.
Over the next hour, he demonstrated how difficult that restraint could be. A Meta bounce recovered an earlier loss, then continued much further after he sold. Meanwhile, he stayed with a slow Novavax position. By the end, the contrast was frustrating him more than the sideways market itself.
Sprouts required patience tied to a price
Sprouts Farmers Market had fallen after earnings, attempted a recovery and rolled over. Glick was watching for his familiar sequence: a break lower that failed, a recovery and then a move through VWAP.
The first two stages had appeared, but the stronger breakout was slow to arrive. He said the stock had not yet violated the area that would invalidate the position. Waiting was justified by that price condition, even if the trade felt inactive.
When Sprouts finally reached roughly $79.15 to $79.20, he discussed selling part of the position. He then raised the stop reference to approximately $78.63 while leaving room for a possible further advance.
The sequence mattered more than the elapsed time. An hour without much progress was not by itself his reason to exit, but a move into an earlier trading area was a reason to take something off.
The QQQ short had already done its job
QQQ was his principal winning trade earlier that morning. Despite having recently said he would stop shorting it, Glick acted when price broke several references, including the prior day's low.
He described the trade as short-lived and reported covering as the decline began reversing. He also acknowledged missing the long trade that followed.
For the rest of the morning, he was wary of repeatedly selling into the bottom of the range. The market was buying declines back up. A completed short did not make each subsequent dip another entry.
He still had a bearish scenario for the next day: a recovery and earnings-related gap followed by a rollover through Thursday's lows. It depended on that sequence developing. He also acknowledged that the market could simply gap higher and continue rising instead.
Meta changed from a loss into a missed extension
Glick's first Meta attempt failed. He bought a recovery, saw it roll over and took a small loss. The stock then produced another bounce that was rejected around VWAP.
Later, he watched a fresh low fail and price recover again. In a range-bound session, he was willing to buy that reversal with the low as his reference and the return toward VWAP as the first objective.
This time the bounce worked. Glick said it recovered what he had lost earlier, and he sold the small position. Meta subsequently moved through VWAP and continued higher.
He became increasingly annoyed as the stock advanced without him. He had treated the initial retracement as enough, while the chart was developing a larger move. He said he should have retained part of the position, although his holding had been only 50 shares.
The later rally did not erase the earlier failed attempt. Both occurred in the same session, with the stock repeatedly revisiting the pattern he was trying to trade.
Novavax exposed the opposite impulse
Novavax moved much more slowly. Glick described buying around $8.43 to $8.45 and waiting for a break through the prior-day VWAP.
He continued holding because the trade had not broken down, but the lack of movement was wearing on him. At one point, a few cents of progress stood in sharp contrast to the dollars Meta had gained after his exit.
He identified the behavioral problem himself: he could be extremely patient while waiting for an unproductive position to improve, then anxious to sell once a trade was making money.
Novavax was still open near the end of the broadcast. Meta was still the move he wished he had managed differently. His frustration came from the two decisions side by side, not from a lack of ideas to trade.
Questions and answers
#Questions answered in the original 2025-10-30 episode.
What did Glick mean by squadouch?
A choppy, largely sideways market where upward moves attracted sellers and downward moves attracted buyers. He warned that forcing repeated trades could turn small losses into a disappointing day.
Why did he continue watching Sprouts despite little early progress?
The stock had not violated the area that would invalidate the setup. When it reached his next reference, he discussed a partial sale and a higher stop.
What bothered him about Meta and Novavax?
He sold the Meta bounce and watched it continue higher, while staying patient with a Novavax position that barely moved. He recognized the tendency to give slow trades more time than profitable ones.
Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .